David Cantor was introduced to antibody manufacturing as a child through his parents’ dedication to the industry. Tom and Cheryl Cantor founded Scantibodies Laboratory in 1976 and raised their three sons alongside their growing business.
Fascinated with the industry, David studied Biology at Bob Jones University and began his career in 1996 as Head of Business Development at Scantibodies Laboratory. David focused on continuing his training while helping assay manufacturers solve raw material challenges through the development of reliable solutions.
20 years of experience and commitment amounted to a preeminent moment in 2016, the Foundation of Cantor BioConnect. David’s life long passion for the advancement of healthcare is realized through his company’s mission to assist pharmaceutical and diagnostic manufacturers with the identification and sourcing of biospecimen samples for production and assay validation.
Cantor BioConnect is located in Southern California serving in-vitro diagnostics and pharmaceutical companies worldwide with tissues, serum/plasma, antibodies, and clinical specimens.